TB Treatment: DOT vs. VOT

Article Sidebar

PDF
Published: Apr 30, 2018
Keywords:
DOTS (Directly-Observed Treatment, Short-course) VOT (Vvideo-Observed Treatment)

Main Article Content

พันธ์ชัย รัตนสุวรรณ
School of Medicine, Walailak University, Nakhon Si Thammarat

Abstract

          DOT (Directly-Observe Treatment) has been still recommended in the latest WHO’s TB Treatment Guidelines in 2017. But VOT (Video-Observed Treatment) has been developed to reduce time and travelling cost of TB patients. However, under the Non-Family DOT, some TB patients who came to health-service units every day did not actually take TB medicines. Furthermore, for providing DOT service, TB drugs should be inspected for changing colors or deterioration, TB drugs should be kept in the suitable place, severe drug side effects should be looked for and DOT can develop relationship with the patients. Therefore, VOT should not be the main measure in replacement of DOT, but it should only be the supporting activity to strengthen the effectiveness of DOT.

Article Details

How to Cite
รัตนสุวรรณ พ. (2018). TB Treatment: DOT vs. VOT. Journal of Bamrasnaradura Infectious Diseases Institute, 12(1), 43–47. retrieved from https://he01.tci-thaijo.org/index.php/bamrasjournal/article/view/185407
Issue
Vol. 12 No. 1 (2018): Journal of Bamrasnaradura Infectious Diseases Institute Vol12 No.1
Section
Academic Article

References

1. World Health Organization. Global tuberculosis report 2017. Geneva: WHO. WHO/HTM /TB/ 2017.23. 2017.

2. World Health Organization. Treatment of tuberculosis: guidelines for national programs. 3rd ed. Geneva: WHO. WHO/CDS/TB/2003. 313. 2013.

3. Rattanasuwan P. TB treatment with DOT: RCT vs. effective program management. Walailak J Sci & Tech 2015; 12: 581-5.

4. World Health Organization. WHO Report on the tuberculosis epidemic: DOTS stop TB at the source. Geneva: WHO. WHO/TB/95.183. 1995.

5. World Health Organization. The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva: WHO. WHO/HTM/TB/2006.368. 2006.

6. World Health Organization. The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015 [internet]. Geneva: WHO; 2018 [cited2018May9]. 2p. Available from: http://www.who.int/tb/strategy/End_TB_Strategy.pdf?ua=1

7. World Health Organization. Treatment of tuberculosis: guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva: WHO. WHO/HTM/TB/2017. 05. 2017.

8. พันธ์ชัย รัตนสุวรรณ, ชลดา ยวนแหล, ผกาวัลย์ แดหวา. การดำเนินงาน DOT (Directly-Observed Treatment) โดยมอบหมายการเป็นพี่เลี้ยงให้บุคคลอื่นที่ไม่ใช่ญาติผู้ป่วย: รูปแบบของศูนย์วัณโรคเขต 11 นครศรีธรรมราช ในปีงบประมาณ 2542-2543. สงขลานครินทร์เวชสาร 2545; 20: 69-78.

9. Rattanasuwan P, Yuanlae C, Daewa P, Imduang K. 12-Year treatment outcomes of tuberculosis patients: a full-scale non-family DOT model in Thailand. Walailak J Sci & Tech 2015; 12: 587-93.

10. พันธ์ชัย รัตนสุวรรณ. Non-family DOT: แนวทาง การควบคุมวัณโรคอย่างมีประสิทธิภาพ [อินเทอร์เน็ต].[เข้าถึงเมื่อ 10 มีนาคม 2561]. เข้าถึงได้จาก:https://goo.gl/i66SEG

11. World Health Organization. Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: WHO. WHO/HTM/TB/2017.30. 2017.

12. Chuck C, Robinson E, Macaraig M, Alexander M, Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City. Int J Tuberc Lung Dis 2016; 20: 588-93.

13. Wade VA, Karnon J, Eliott JA, Hiller JE. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation. PLoS ONE [internet]. 2012 [cited 2018 May 9]; 7(11): e50155. doi.org/10.1371/ journal.pone.0050155.

14. Centers for Disease Control and Prevention, United States of America. Improving patient adherence to tuberculosis treatment, revised 1994. Atlanta: CDC; 1994.